Why MorphoSys Shares Are Trading Lower By Around 32%; Here Are 30 Stocks Moving Premarket




Don’t forget to check out our premarket coverage here .


  • MorphoSys AG MOR shares fell 31.8% to $3.74 in pre-market trading. MorphoSys’ licensing partner Roche issued an update on Phase 3 GRADUATE program for Gantenerumab in early Alzheimer’s disease.
  • Tremor International Ltd TRMR fell 25.5% to $6.57 in pre-market trading after gaining over 5% on Friday.
  • Core Scientific, Inc. CORZ fell 14.2% to $0.1699 in pre-market trading after surging 44% on Friday.
  • Fast Radius, Inc. FSRD shares fell 13.5% to $0.2098 in pre-market trading after dropping around 7% on Friday.
  • Sterling Infrastructure, Inc. STRL shares fell 9.7% to $28.98 in pre-market trading. Sterling Infrastructure recently reported better-than-expected Q3 results and issued FY22 guidance above estimates.
  • Cabaletta Bio, Inc. CABA fell 8.4% to $2.18 in pre-market trading after jumping 17% on Friday. Cabaletta Bio recently posted a Q3 loss of $0.39 per share.
  • Amyris, Inc. AMRS fell 8.1% to $2.03 in pre-market trading after jumping 20% on Friday.
  • ShiftPixy, Inc. PIXY fell 5.8% to $18.00 in pre-market trading after jumping over 56% on Friday.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!